mensalgin tabletti
schering oy - kofeiini,phenazonum,beta-pyridylcarbinoli maleas,codeini phosphas hemihydricus - tabletti - fenatsoni, yhdistelmävalmisteet
recormon 1000 iu injektiokuiva-aine
orion oyj - epoetinum beta - injektiokuiva-aine - 1000 iu - epoetiini
mibg i-123 74 mbq/ml injektioneste, liuos
curium netherlands b.v. - 3-iodobenzylguanidine sulphate, iobenguane (123 i) beta - injektioneste, liuos - 74 mbq/ml - jodi(123i)jobenguani
recormon 2000 iu injektiokuiva-aine
orion oyj - epoetinum beta - injektiokuiva-aine - 2000 iu - epoetiini
recormon 5000 iu injektiokuiva-aine
orion oyj - epoetinum beta - injektiokuiva-aine - 5000 iu - epoetiini
recormon 10000 iu injektiokuiva-aine
orion oyj - epoetinum beta - injektiokuiva-aine - 10000 iu - epoetiini
heptavac injektioneste, suspensio
intervet international b.v. - clostridium novyi -toksoidi,clostridium perfringens beta (b) -toksoidi,clostridium perfringens beta (c) -toksoidi,clostridium septicum -toksoidi,clostridium chauvoei -bakteeri (inaktivoitu) ja -toksoidi,clostridium perfringens epsilon (d) -toksoidi,tetanustoksoidi - injektioneste, suspensio - klostridirokote
porcilis coli 6c injektioneste, suspensio
intervet international b.v. - escherichia coli f4ab -antigeeni,escherichia coli f4ac -antigeeni,escherichia coli f6 -antigeeni,clostridium perfringens beta (b) -toksoidi,clostridium perfringens beta (c) -toksoidi,escherichia coli f5 -antigeeni,clostridium perfringens epsilon (d) -toksoidi - injektioneste, suspensio
tribovax vet. injektioneste, suspensio
intervet international b.v. - clostridium perfringens beta toxoid, type b, clostridium perfringens beta toxoid, type c, clostridium perfringens epsilon toxoid, type d, clostridium septicum toxoid, clostridium novyi toxoid, clostridium chavoei bacterium (inactivated) and toxoid, clostridium perfringens type a alpha toxoid, clostridium tetani toxoid, clostridium sordellii toxoid, clostridium haemolyticum toxoid - injektioneste, suspensio - klostridirokote
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - hemostaatit - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.